Despite a one-time $45 million cash infusion from California, Sonoma State University won't bring its athletics program back.

California lawmakers announced the additional financial support months after the university proposed sweeping cuts due to budget issues. Now some cuts will be reversed. The roller-coaster saga of ...

MINNEAPOLIS — Patients with trigeminal neuralgia experienced relief with IV magnesium and methocarbamol, according to data presented at the American Headache Society 67th Annual Scientific ...

WASHINGTON—President Trump said he terminated trade talks with Canada over what he called an “egregious” digital-services tax on U.S. tech companies, plunging relations with America’s ...

Reclast (zoledronic acid or zoledronate) is an infusion to treat osteoporosis. It's typically covered by Original Medicare (parts A and B).

Discover the four key trends and innovations driving infusion therapy for chronic diseases as we head into 2025. Stay informed and up-to-date on the latest advancements in healthcare.

THE SECURITIES and Exchange Commission (SEC) has discontinued the use of joint certification for applications to increase capital stock through cash infusion due to weak public adoption.

In amongst a clutch of discontinued phase 3 programmes in Roche's fourth-quarter results update was the news that it has stopped a study of AKT inhibitor ipatasertib as a treatment for first-line ...